Thought Leader Select Announces Key Opinion Leader Assessments in Chronic Pain, Colorectal Surgery, and Gastroenterology

New Press Release from the Offices of Thought Leader Select

February 2, 2012 (Chapel Hill, NC) Thought Leader Select is pleased to announce a pair of key opinion leader (KOL) identification and profiling projects to support the development pipeline of a leading pharmaceutical client focused in the therapeutic area of gastroenterology.

In the first research assessment, Thought Leader Select will identify and profile leading medical experts in the treatment of patients suffering from non-cancer-related chronic pain.  The company will identify the leading pain experts throughout the United States by examining the skills and experiences of physicians in multiple disciplines and specialties, including gastroenterologists, primary care physicians, nurse practitioners, and physician assistants.

For the second research assessment, Thought Leader Select will identify and profile 100 key opinion leaders in colorectal surgery, as well as 125 KOLs in gastroenterology. The cumulative group of 225 physician thought leaders will share vast experience in research and treatment of fecal incontinence.

Thought Leader Select will use its validated, objective deep profiling methodology to assess the skills and experience of the thought leaders chronic pain, colorectal surgery, and gastroenterology in multiple research categories, including their areas of expertise, medical/scientific journal publishing history, and participation in basic and clinical research.  The company’s research group is comprised of subject-matter experts in medicine, with decades of experience working in medical research and clinical settings in the United States, Canada, Australia, and Africa.

Typically, key opinion leaders serve on scientific advisory boards and participate in late-stage clinical trials to monitor the effectiveness of new drugs in larger patient populations.

“We are very pleased to be working again with this client, a company making great strides in the development of medicines to treat chronic pain and gastroenterological conditions,” stated Paul Meade, President of Thought Leader Select. “They have always understood that the best way to ultimately make the lives of patients better is to work with the right key opinion leaders in the development of new treatments.  We are thankful they’ve chosen us to help them find the right physicians to advise them on the best ways to bring better health to millions of patients.”

About Thought Leader Select

Thought Leader Select serves the biopharmaceutical and healthcare industries, as well as the medical community at large by assessing medical experts (known as “thought leaders” and “key opinion leaders”) within a host of therapeutic areas such as diabetes, oncology, and neurology.

Over two dozen of the top 50 global biopharmaceutical and healthcare companies count on our expertise when seeking to launch new medications for better public health, ensuring that they are collaborating with the right medical professionals for the right reasons—their skills and experiences.

Media Contact:

Brian Castle

Director of Global Marketing and Client Relations

Phone: 919-360-9690


More Posts

Technology is Getting Smarter

By Paul Meade, Patient Engagement Lead  It has become apparent that in order for a healthcare organization to succeed, they need to be able to


Send Us A Message